Medicomply Aps: Financial statements 2023
CVR: 40538399
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Medicomply Aps (CVR 40538399) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 819,340 and a net result of DKK 239,249 compared with DKK 120,187 the year before. That is an increase of 18.6% compared with the year before. Equity in the 2023 report amounted to DKK 917,251. The solvency ratio was 67.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 819,340
- Profit/Loss
- DKK 239,249
- Equity
- DKK 917,251
- Total Assets
- DKK 1,358,995
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 819K | 239K | 917K | 1 |
| 2022 | - | 691K | 120K | 604K | 1 |
| 2021 | - | 813K | 262K | 484K | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Medicomply Aps has published its annual report for 2022. Gross profit came to DKK 690,674, and the net result was DKK 120,187.
About Medicomply Aps
Medicomply Aps is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2019. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of John Erik Bech Hansen. The board consists of John Erik Bech Hansen (chair). The company is owned by BECH HOLDING 2007 ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 837,602 and a net result of DKK 170,695 compared with DKK -181,661 the year before. Equity in the 2025 report amounted to DKK 306,286.